MedPath

Radio-frequency-ablation for lung cancer under general anesthesia

Phase 2
Conditions
Primary lung cancer and metastatic lung cancer
Registration Number
JPRN-UMIN000050454
Lead Sponsor
Kashiwa Kousei General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
500
Inclusion Criteria

Not provided

Exclusion Criteria

Sever pulmonary dysfunction

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
safety and efficacy
Secondary Outcome Measures
NameTimeMethod
5 years recurrence-free survival
© Copyright 2025. All Rights Reserved by MedPath